Acquisition by Green Nicholas Stewart of 119973 shares of Avid Bioservices subject to Rule 16b-3
CDMODelisted Stock | USD 12.49 0.00 0.00% |
About 56% of Avid Bioservices' investor base is looking to short. The analysis of overall sentiment of trading Avid Bioservices stock suggests that many investors are alarmed at this time. Avid Bioservices' investing sentiment overview a quick insight into current market opportunities from investing in Avid Bioservices. Many technical investors use Avid Bioservices stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Avid |
Filed transaction by Avid Bioservices Director, Officer: President & Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Avid Bioservices Fundamental Analysis
We analyze Avid Bioservices' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avid Bioservices using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avid Bioservices based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Avid Bioservices is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Avid Bioservices Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avid Bioservices stock to make a market-neutral strategy. Peer analysis of Avid Bioservices could also be used in its relative valuation, which is a method of valuing Avid Bioservices by comparing valuation metrics with similar companies.
Peers
Avid Bioservices Related Equities
MGTX | MeiraGTx Holdings | 6.88 | ||||
LYRA | Lyra Therapeutics | 5.00 | ||||
CRNX | Crinetics Pharmaceuticals | 1.63 | ||||
ADAG | Adagene | 0.98 | ||||
IDYA | Ideaya Biosciences | 0.55 | ||||
MLYS | Mineralys Therapeutics, | 0.31 | ||||
IMCR | Immunocore Holdings | 0.17 | ||||
DYN | Dyne Therapeutics | 0.14 | ||||
KROS | Keros Therapeutics | 0.09 | ||||
EWTX | Edgewise Therapeutics | 0.11 | ||||
MIRM | Mirum Pharmaceuticals | 1.34 | ||||
ANAB | AnaptysBio | 1.48 | ||||
CYTK | Cytokinetics | 1.68 | ||||
LRMR | Larimar Therapeutics | 2.45 | ||||
BCYC | Bicycle Therapeutics | 2.83 | ||||
ACRV | Acrivon Therapeutics, | 5.30 | ||||
KALV | Kalvista Pharmaceuticals | 5.73 | ||||
ANEB | Anebulo Pharmaceuticals | 11.27 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |